by Marti Soler | Oct 26, 2022 | Country Profile
Country Profile: United Kingdom VIEW ATLAS Recommendations Children:All children under the age of 21 At-risk groups:All people aged 2 to 64 with asplenia or dysfunction of the spleen, chronic respiratory/heart/kidney/liver disease, diabetes, immunosuppression,...
by Marti Soler | Oct 26, 2022 | Country Profile
Country Profile: Türkiye VIEW ATLAS Recommendations Children:Children aged 2 to 12 months At-risk groups:At-risk groups including adults with an immunocompromising condition; functional or anatomic asplenia; CSF leak; cochlear implants; people under 65 with chronic...
by Marti Soler | Oct 26, 2022 | Country Profile
Country Profile: Switzerland VIEW ATLAS Recommendations Children:Children aged 2 to 12 months At-risk groups:At-risk groups including patients with asplenia or hyposplenia (sickle cell anemia); haemoglobinopathy; HIV infection; antibody deficiency; leukemia;...
by Marti Soler | Oct 26, 2022 | Country Profile
Country Profile: Sweden VIEW ATLAS Recommendations Children:Children aged 3 to 12 months At-risk groups:At-risk groups aged 2-64, including asplenia or hyposplenia; CSF leak; immunocompromised people, such as people who have undergone stem cell or bone marrow...
by Marti Soler | Oct 26, 2022 | Country Profile
Country Profile: Slovenia VIEW ATLAS Recommendations Children:Children aged 3 to 18 months At-risk groups:At-risk groups at a national level Older adults:All people over the age of 65 Coverage figures (2021) Children: 58.20% At-risk groups: – Older adults:...
by Marti Soler | Oct 26, 2022 | Country Profile
Country Profile: Slovakia VIEW ATLAS Recommendations Children:Children aged 2 to 12 months At-risk groups:No recommendation Older adults:All people over the age of 60 Coverage figures (2021) Children: 96.86% At-risk groups: – Older adults: – Vaccination...
